170 related articles for article (PubMed ID: 29078840)
1. Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States.
Jinjuvadia R; Salami A; Lenhart A; Jinjuvadia K; Liangpunsakul S; Salgia R
Am J Med Sci; 2017 Oct; 354(4):362-369. PubMed ID: 29078840
[TBL] [Abstract][Full Text] [Related]
2. Mortality and hospital utilization for hepatocellular carcinoma in the United States.
Kim WR; Gores GJ; Benson JT; Therneau TM; Melton LJ
Gastroenterology; 2005 Aug; 129(2):486-93. PubMed ID: 16083705
[TBL] [Abstract][Full Text] [Related]
3. The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample.
Mishra A; Otgonsuren M; Venkatesan C; Afendy M; Erario M; Younossi ZM
Liver Int; 2013 Sep; 33(8):1281-6. PubMed ID: 23710596
[TBL] [Abstract][Full Text] [Related]
4. Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults.
Hirode G; Saab S; Wong RJ
JAMA Netw Open; 2020 Apr; 3(4):e201997. PubMed ID: 32239220
[TBL] [Abstract][Full Text] [Related]
5. Trends and outcomes of transarterial chemoembolization in hepatocellular carcinoma: a national survey.
Mumtaz K; Patel N; Modi RM; Patel V; Hinton A; Hanje J; Black SM; Krishna S
Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):624-630. PubMed ID: 29291782
[TBL] [Abstract][Full Text] [Related]
6. Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States.
Jinjuvadia R; Liangpunsakul S;
J Clin Gastroenterol; 2015 Jul; 49(6):506-11. PubMed ID: 25198164
[TBL] [Abstract][Full Text] [Related]
7. Trends of Hepatocellular Carcinoma (HCC) Inpatients Mortality and Financial Burden From 2011 to 2017: A Nationwide Analysis.
Wakil A; Wu YC; Mazzaferro N; Greenberg P; Pyrsopoulos NT
J Clin Gastroenterol; 2024 Jan; 58(1):85-90. PubMed ID: 36729749
[TBL] [Abstract][Full Text] [Related]
8. The burden of illness associated with hepatocellular carcinoma in the United States.
Lang K; Danchenko N; Gondek K; Shah S; Thompson D
J Hepatol; 2009 Jan; 50(1):89-99. PubMed ID: 18977551
[TBL] [Abstract][Full Text] [Related]
9. Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States.
Konyn P; Perumpail BJ; Wijarnpreecha K; Cholankeril G; Ahmed A; Kim D
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):113-119. PubMed ID: 38353612
[TBL] [Abstract][Full Text] [Related]
10. Trends and burden of firearm-related hospitalizations in the United States across 2001-2011.
Agarwal S
Am J Med; 2015 May; 128(5):484-92.e1. PubMed ID: 25554375
[TBL] [Abstract][Full Text] [Related]
11. Decreasing mortality and hospitalizations with rising costs related to gastric cancer in the USA: an epidemiological perspective.
Liu D; Mehta D; Kaur S; Kumar A; Parikh K; Chawla L; Patel S; Devi A; Saha A
J Hematol Oncol; 2018 Dec; 11(1):138. PubMed ID: 30545376
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical trends in the management of unruptured cerebral aneurysms in the United States: analysis of nationwide database over a 10-year period.
Huang MC; Baaj AA; Downes K; Youssef AS; Sauvageau E; van Loveren HR; Agazzi S
Stroke; 2011 Jun; 42(6):1730-5. PubMed ID: 21493902
[TBL] [Abstract][Full Text] [Related]
13. Rising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993-2005).
Marinho RT; Giria J; Moura MC
World J Gastroenterol; 2007 Mar; 13(10):1522-7. PubMed ID: 17461443
[TBL] [Abstract][Full Text] [Related]
14. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
15. Treatment and Cost of Hepatocellular Carcinoma: A Population-Based Cohort Study in Taiwan.
Nguang SH; Wu CK; Liang CM; Tai WC; Yang SC; Ku MK; Yuan LT; Wang JW; Tseng KL; Hung TH; Hsu PI; Wu DC; Chuah SK; Hsu CN
Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486324
[TBL] [Abstract][Full Text] [Related]
16. Financial burden in a US cohort of patients with HCC.
Desai R; Jiang Y; VanWagner LB; Singal AG; Lieber SR
Hepatol Commun; 2024 Jun; 8(6):. PubMed ID: 38829203
[TBL] [Abstract][Full Text] [Related]
17. Incidence and cost of treating axis fractures in the United States from 2000 to 2010.
Daniels AH; Arthur M; Esmende SM; Vigneswaran H; Palumbo MA
Spine (Phila Pa 1976); 2014 Aug; 39(18):1498-505. PubMed ID: 24859578
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and cost of a hepatocellular carcinoma screening program at an Australian teaching hospital.
Qian MY; Yuwei J R; Angus P; Schelleman T; Johnson L; Gow P
J Gastroenterol Hepatol; 2010 May; 25(5):951-6. PubMed ID: 20546449
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Economic Burden of Hospitalizations for Infective Endocarditis in the United States.
Alkhouli M; Alqahtani F; Alhajji M; Berzingi CO; Sohail MR
Mayo Clin Proc; 2020 May; 95(5):858-866. PubMed ID: 31902529
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced, dementia-associated and non-dementia, non-drug delirium hospitalizations in the United States, 1998-2005: an analysis of the national inpatient sample.
Lin RY; Heacock LC; Fogel JF
Drugs Aging; 2010 Jan; 27(1):51-61. PubMed ID: 20030432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
